Followers | 9 |
Posts | 1165 |
Boards Moderated | 0 |
Alias Born | 03/20/2022 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 20, 2023 5:33:39 AM
As I previously mentioned, either the rvv med team is simply inept at comprehending what the fda requires, or the fda is constantly moving the goal posts re what they require for approval of the ep submission.
I can think of no reasons why rvv would deliberately want to continuously delay the process by providing substandard submissions.
There is no present need for additional trial data, nor do I believe that any data from dr fahy's research at ucsf will have little impact on the ep change request so a desire for delays is simply not there.
I am tending to believe that the fda (among others) is at the root of this obvious farce and that the link below possibly indicates the reason why................
FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM